Covid-19 Impact on Point-of-Care Glucose Testing Market Size to surge at 2.82% CAGR is expected to reach $7,308.69 Million in 2025

According to a recent report published by Grand View Research Inc., the convenience of operation has largely favored the growing usage of glucose meters across medical settings and is driving the point-of-care glucose market expansion.

According to a report, “Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019–2025”, published by Grand View Research, Inc. The global point-of-care glucose testing market size is expected to reach USD 7,308.69 million by 2025, registering a CAGR of 2.82%, as per a new report by Grand View Research Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside.

Various companies are keen on developing non-invasive needle-less blood glucose monitoring kits to offer painless glucose detection in patients. For instance, GlucoTrack has been developed by Integrity Applications (Israel) and is capable of performing quantification using ultrasonic, electromagnetic, and thermal waves in combination. Furthermore, Eversense is another widely accepted painless glucose monitoring subcutaneous implant developed by Senseonics and shows the results in real time.

The latest no-code monitoring systems are aiding in minimizing the errors that can occur due to improper entry of strip codes. Whereas, some market players are incorporating noble metals such as gold, silver, and platinum to effectively reduce the electrical noise further enhancing result accuracy.

To request a sample copy or view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/point-of-care-glucose-testing-market/request/rs1

Point-of-Care Glucose Testing Market Highlights

1. University of Toronto researchers have developed a point-of-care diagnostic test kit using a glucose meter to diagnose a number of diseases, including the novel coronavirus. The effort is aimed to develop an affordable and off-the-shelf Covid-19 kit using a glucose meter and support the existing healthcare infrastructure
2. Electrochemical sensor employed for glucose testing by Exhalation Technology (ETL) is now used by the company to develop the CoronaCheck point-of-care diagnostic test in exhaled breath condensate (EBC). The device was approved by the FDA in January 2021 and gained the emergency use authorization in hospitals, airports, care homes, schools retail outlets, and similar spaces
3. In September 2020, the US Food and Drug Administration (FDA) rolled out guidance providing recommendations for the over-the-counter and manufacturing of point-of-care BGMSs
4. In terms of revenue, Accu-Chek Inform II led the market in 2018 and is projected to maintain this trend throughout the analysis timeline
5. Bayer CONTOUR blood glucose monitoring system is anticipated to expand at a staggering growth rate of 5.5% from 2019–2025, considering its growing demand
6. North America is the leading regional market, on account of the presence of a robust healthcare system and is home to some of the market giants such as Nova Biomedical, Abbott, and Prodigy Diabetes Care, LLC.

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market report based on product and region:

• Product Outlook {Revenue (USD Million) and Volume (Thousand Units), 2014–2025}
• Accu Check Aviva Meter
• Onetouch Verio Flex
• i-STAT
• Bayer CONTOUR blood glucose monitoring system
• Freestyle Lite
• True Metrix
• Accu-Chek Inform II
• StatStrip
• Regional Outlook {Revenue (USD Million) and Volume (Thousand Units), 2014–2025}
• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Asia Pacific
• China
• Japan
• India
• Korea
• Australia
• Singapore
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa

List of Key Players in Point-of-Care Glucose Testing Market

1. F. Hoffmann-La Roche Ltd.
2. Abbott Laboratories
3. Nipro Corp.
4. Nova Biomedical
5. ACON Laboratories, Inc.
6. Trinity Biotech
7. Prodigy Diabetes Care, LLC
8. Bayer AG/Ascensia Diabetes Care Holdings AG
9. EKF Diagnostics